Mizuho Securities Raises Price Target on Ironwood Pharma (IRWD) as Milestone Drives 1Q Beat

May 10, 2016 6:43 AM

Mizuho Securities reiterated a Buy rating on Ironwood Pharmaceuticals (NASDAQ: IRWD), and raised the price target to $16.00 (from $15.00) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found